Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07519707

Video Intervention to Improve Understanding of Diabetic Retinopathy at Zuckerberg San Francisco General Hospital and Trauma Center

The study will evaluate whether videos can improve understanding of diabetic eye disease, and follow-up rates in the eye clinic.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Zuckerberg San Francisco General Hospital and Trauma Center

San Francisco, California, 94110, United States

Location contact

Sriranjani Padmanabhan, MD

CONTACT

[email protected]

415-353-2020

About this study

Health literacy is a prevalent issue at Zuckerberg San Francisco General Hospital, particularly at the eye clinic where understanding of diagnoses and treatment plans largely affect vision outcomes. This study will determine whether video-based explanations, created in both English and Spanish, of diabetic retinopathy can improve knowledge concordance and follow up rates among patients in the eye clinic. Knowledge concordance and patient satisfaction will be assessed through digital surveys in Qualtrics.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Diagnosis of diabetes mellitus with or without diabetic retinopathy
  • Scheduled visit to ZSFG clinic is specifically for diabetes mellitus or diabetic retinopathy care
  • Able to speak and understand English or Spanish

Exclusion criteria

  • Unable to view or understand the videos due to significant vision obstruction or impairment

Treatment and study plan

Animated Videos

Behavioral

Animated videos (in English and Spanish) that describe diabetic retinopathy.

Primary outcomes

  1. Change in Knowledge Concordance Assessed through Validated Questionarres

    Time frame: 12 months

    Validated questionnaires in Qualtrics consisting of multiple choice questions and scales from 0 through 10 will be used to assess knowledge concordance before and after the patient's appointment. The change in concordance will be determined for each patient.

Secondary outcomes

  1. Follow Up Adherence, Assessed through Electronic Record Review

    Time frame: 12 months

    The number of scheduled follow-up appointments versus the number of attended follow-up appointments will be compared for each patient through electronic record review.

  2. Diabetic Retinopathy Progression, Assessed through Electronic Health Record Review

    Time frame: 12 months

    Electronic health records and ocular imaging will be reviewed to determine whether patients' diabetic retinopathy has progressed or improved. The numbers of patients with mild, moderate, severe, and proliferative diabetic retinopathy will be compared between groups at the end of the study period.

Study contacts

Contact information is provided by the study sponsor or research team.

Sriranjani Padmanabhan, MD

CONTACT

[email protected]

415-353-2020

Sponsors and collaborators

Lead sponsor

University of California, San Francisco

Other

Registry information

Official study title

Addressing Low Patient Follow-up Rates Among Patients With Diabetes in the Eye Clinic at Zuckerberg San Francisco General Hospital and Trauma Center

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
Apr 9, 2026
Registry last updated
Jul 22, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.